Home>
US Stocks>
Edwards Lifesciences Corp.

Edwards Lifesciences Corp. share price today

(EW)

Edwards Lifesciences Corp. share price is $74.2 & ₹6,284.67

$74.2

▲

(5.7%)

Market is closed - opens 8 PM, 05 Dec 2024

View live Edwards Lifesciences Corp. share price in Dollar and Rupees. Guide to invest in Edwards Lifesciences Corp. from India. Also see the sentimental analysis on Indian investors investing in Edwards Lifesciences Corp.. Get details on the Indian mutual funds that are investing in Edwards Lifesciences Corp.. Get Analyst recommendations and forecasts along with all the Edwards Lifesciences Corp.'s financials.

Edwards Lifesciences Corp. share price movements

$72.33
$74.48
$74.20
2.52%
Downside
Day's Volatility :2.89%
Upside
0.38%
$58.93
$96.12
$74.20
20.58%
Downside
52 Weeks Volatility :38.69%
Upside
22.8%

Edwards Lifesciences Corp. Returns

Period	Edwards Lifesciences Corp.	Sector (Health Care)	S&P500
3 Months	6.83%	-4.7%	9.9%
6 Months	-19.56%	0.9%	13.0%
1 Year	1.5%	11.6%	32.5%
3 Years	-37.0%	12.9%	33.3%

Edwards Lifesciences Corp. Key Statistics

in dollars & INR

Market Capitalization	$42.5B
Revenue TTM	$6.3B
EBITDA	$2.1B
Earnings Per Share (EPS)	$2.59
PE Ratio	27.55
Profit Margin	65.86%
Quarterly Earnings Growth YOY	7.16%
Return On Equity TTM	19.14%

How to invest in Edwards Lifesciences Corp. from India?

It is very easy for Indian residents to invest directly in Edwards Lifesciences Corp. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Edwards Lifesciences Corp. stock in both rupees (INR) and dollars (USD). Search for Edwards Lifesciences Corp. or EW on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Edwards Lifesciences Corp. or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Edwards Lifesciences Corp. shares which would translate to 0.011 fractional shares of Edwards Lifesciences Corp. as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Edwards Lifesciences Corp.

-27%

Period: Sep 5, 2024 to Dec 4, 2024. Change in 30 Days versus previous period

Search volume for Edwards Lifesciences Corp. on INDmoney from India has reduced in the last 30 days as on Dec 5, 2024. -27% less investors are searching Edwards Lifesciences Corp. in the last 30 days versus the previous period.

Indian Mutual Funds that own Edwards Lifesciences Corp.

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	5177	9.32	0.08%

Global Institutional Holdings in Edwards Lifesciences Corp.

Vanguard Group Inc
10.61%
BlackRock Inc
8.64%
Wellington Management Company LLP
5.35%
State Street Corp
4.45%
Bank of New York Mellon Corp
3.10%
Geode Capital Management, LLC
2.29%

Analyst Recommendation on Edwards Lifesciences Corp.

Buy

60%Buy

35%Hold

5%Sell

Based on 40 Wall street analysts offering stock ratings for Edwards Lifesciences Corp.(by analysts ranked 0 to 5 stars)

Based on 40 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Edwards Lifesciences Corp.

What analysts predicted

Upside of 3.24%

Current:

$74.20

Target:

$76.61

Insights on Edwards Lifesciences Corp.

Decreasing Revenue
Edwards Lifesciences Corp. has experienced a decline in revenue for the last three quarters. Revenue decreased from $1.59 billion to $1.35 billion, reflecting an average decrease of 7.8% per quarter.
Increasing Net Profit
Edwards Lifesciences Corp. has shown strong profit growth over the last three quarters. Their net profit increased from $351.9 million to $3.07 billion, which is an average rise of 46.0% each quarter.
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 64.8% return, outperforming this stock by 62.4%
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 129.2% return, outperforming this stock by 164.2%

Edwards Lifesciences Corp. Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$3.7B	↑ 8.37%
Net Income	$722.2M	↑ 16.09%
Net Profit Margin	19.4%	↑ 1.29%

	FY19	Y/Y Change
Revenue	$4.3B	↑ 16.79%
Net Income	$1.0B	↑ 44.96%
Net Profit Margin	24.08%	↑ 4.68%

	FY20	Y/Y Change
Revenue	$4.4B	↑ 0.88%
Net Income	$823.4M	↓ 21.35%
Net Profit Margin	18.77%	↓ 5.31%

	FY21	Y/Y Change
Revenue	$5.2B	↑ 19.29%
Net Income	$1.5B	↑ 82.55%
Net Profit Margin	28.73%	↑ 9.96%

	FY22	Y/Y Change
Revenue	$5.4B	↑ 2.86%
Net Income	$1.5B	↑ 1.25%
Net Profit Margin	28.28%	↓ 0.45%

	FY23	Y/Y Change
Revenue	$6.0B	↑ 11.56%
Net Income	$1.4B	↓ 7.85%
Net Profit Margin	23.35%	↓ 4.93%

	Q2 FY23	Q/Q Change
Revenue	$1.5B	↑ 4.84%
Net Income	$307.1M	↓ 9.81%
Net Profit Margin	20.07%	↓ 3.26%

	Q3 FY23	Q/Q Change
Revenue	$1.5B	↓ 3.22%
Net Income	$384.9M	↑ 25.33%
Net Profit Margin	25.99%	↑ 5.92%

	Q4 FY23	Q/Q Change
Revenue	$1.5B	↑ 3.59%
Net Income	$369.9M	↓ 3.9%
Net Profit Margin	24.11%	↓ 1.88%

	Q1 FY24	Q/Q Change
Revenue	$1.6B	↑ 4.18%
Net Income	$351.9M	↓ 4.87%
Net Profit Margin	22.02%	↓ 2.09%

	Q2 FY24	Q/Q Change
Revenue	$1.4B	↓ 13.28%
Net Income	$366.3M	↑ 4.09%
Net Profit Margin	26.43%	↑ 4.41%

	Q3 FY24	Q/Q Change
Revenue	$1.4B	↓ 2.27%
Net Income	$3.1B	↑ 738.33%
Net Profit Margin	226.73%	↑ 200.3%

	FY18	Y/Y Change
Total Assets	$5.3B	↓ 6.54%
Total Liabilities	$2.2B	↓ 19.19%

	FY19	Y/Y Change
Total Assets	$6.5B	↑ 21.87%
Total Liabilities	$2.3B	↑ 7.17%

	FY20	Y/Y Change
Total Assets	$7.2B	↑ 11.54%
Total Liabilities	$2.7B	↑ 13.8%

	FY21	Y/Y Change
Total Assets	$8.5B	↑ 17.49%
Total Liabilities	$2.7B	↑ 0.15%

	FY22	Y/Y Change
Total Assets	$8.3B	↓ 2.47%
Total Liabilities	$2.5B	↓ 6.78%

	FY23	Y/Y Change
Total Assets	$9.4B	↑ 12.91%
Total Liabilities	$2.6B	↑ 6.36%

	Q2 FY23	Q/Q Change
Total Assets	$9.0B	↑ 4.08%
Total Liabilities	$2.6B	↓ 1.22%

	Q3 FY23	Q/Q Change
Total Assets	$9.4B	↑ 4.07%
Total Liabilities	$2.6B	↑ 3.37%

	Q4 FY23	Q/Q Change
Total Assets	$9.4B	↓ 0.08%
Total Liabilities	$2.6B	↑ 0.0%

	Q1 FY24	Q/Q Change
Total Assets	$9.7B	↑ 3.98%
Total Liabilities	$2.5B	↓ 3.55%

	Q2 FY24	Q/Q Change
Total Assets	$10.1B	↑ 3.73%
Total Liabilities	$2.6B	↑ 1.76%

	Q3 FY24	Q/Q Change
Total Assets	$13.0B	↑ 28.44%
Total Liabilities	$3.4B	↑ 29.49%

	FY18	Y/Y Change
Operating Cash Flow	$926.8M	↓ 7.38%
Investing Cash Flow	$76.7M	↓ 111.85%
Financing Cash Flow	$-1.1B	↑ 132.71%

	FY19	Y/Y Change
Operating Cash Flow	$1.2B	↑ 27.26%
Investing Cash Flow	$-595.8M	↓ 876.79%
Financing Cash Flow	$-115.6M	↓ 89.5%

	FY20	Y/Y Change
Operating Cash Flow	$1.1B	↓ 10.61%
Investing Cash Flow	$-531.1M	↓ 10.86%
Financing Cash Flow	$-486.9M	↑ 321.19%

	FY21	Y/Y Change
Operating Cash Flow	$1.7B	↑ 64.29%
Investing Cash Flow	$-1.7B	↑ 224.33%
Financing Cash Flow	$-356.3M	↓ 26.82%

	FY22	Y/Y Change
Operating Cash Flow	$1.2B	↓ 29.67%
Investing Cash Flow	$252.3M	↓ 114.65%
Financing Cash Flow	$-1.6B	↑ 344.71%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$33.6M	↓ 89.3%
Investing Cash Flow	$70.2M	↑ 13940.0%
Financing Cash Flow	$52.1M	↓ 125.22%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$411.5M	↑ 1124.7%
Investing Cash Flow	$159.7M	↑ 127.49%
Financing Cash Flow	$-143.3M	↓ 375.05%

Edwards Lifesciences Corp. Technicals Summary

Sell

Neutral

Buy

Edwards Lifesciences Corp. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Edwards Lifesciences Corp. Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Edwards Lifesciences Corp.	5.76%	-19.56%	1.5%	-37.0%	-9.69%
Stryker Corporation	5.35%	11.44%	35.35%	53.15%	94.43%
Boston Scientific Corp.	5.72%	18.8%	64.96%	122.19%	106.89%
Abbott Laboratories	-0.78%	12.03%	11.31%	-11.82%	39.28%
Medtronic Plc	-3.5%	5.1%	9.49%	-21.5%	-22.13%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Edwards Lifesciences Corp.	27.55	27.55	6.52	2.53	0.19	0.11	NA	16.18
Stryker Corporation	42.03	42.03	2.74	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	74.93	74.93	1.64	2.46	0.09	0.05	NA	14.05
Abbott Laboratories	36.1	36.1	2.31	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	26.38	26.38	1.56	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Edwards Lifesciences Corp.	Buy	$42.5B	-9.69%	27.55	65.86%
Stryker Corporation	Buy	$149.5B	94.43%	42.03	16.34%
Boston Scientific Corp.	Buy	$133.7B	106.89%	74.93	11.26%
Abbott Laboratories	Buy	$206.3B	39.28%	36.1	13.99%
Medtronic Plc	Buy	$110.6B	-22.13%	26.38	12.06%

About Edwards Lifesciences Corp.

edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.

Organization	Edwards Lifesciences Corp.
Employees	19800
CEO	Mr. Bernard J. Zovighian
Industry	Health Technology

Important FAQs about investing in Edwards Lifesciences Corp. from India :

What is Edwards Lifesciences Corp. share price today?

Edwards Lifesciences Corp. (EW) share price today is $74.20.

Can Indians buy Edwards Lifesciences Corp. shares?

Yes, Indians can invest in the Edwards Lifesciences Corp. (EW) from India.

With INDmoney, you can buy Edwards Lifesciences Corp. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Edwards Lifesciences Corp. at zero transaction cost.

How can I buy Edwards Lifesciences Corp. shares from India?

It is very easy to buy Edwards Lifesciences Corp. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Edwards Lifesciences Corp. be purchased?

Yes, you can buy fractional shares of Edwards Lifesciences Corp. with INDmoney app.

What are the documents required to start investing in Edwards Lifesciences Corp. stocks?

To start investing in Edwards Lifesciences Corp., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.